Cathepsin L in cancer: Context‐dependent functions, microenvironmental regulation and translational opportunities
- 1Department of Oncology Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan China
- 2The First Clinical Medical College of Lanzhou University Lanzhou China
Abstract
Background Cathepsin L (CTSL), a lysosomal cysteine endopeptidase, is implicated in multiple facets of tumour biology beyond its canonical role in intracellular protein turnover. Objective This review provides a comprehensive synthesis of the current evidence regarding CTSL in cancer, evaluating its biochemical constraints, substrate selectivity within the cysteine cathepsin family, and context‐dependent functions across diverse malignancies. Key findings Mechanistically, across solid and haematological malignancies, such as breast and gastrointestinal cancers as well as paediatric acute myeloid leukaemia, CTSL promotes progression and therapy resistance through diverse processes, including extracellular matrix degradation, epithelial–mesenchymal transition, angiogenesis, and cell proliferation. These oncogenic functions are strongly context‐ and lineage‐dependent rather than operating through a universal mechanism. Conversely, in stratified squamous epithelia, including the epidermis and cutaneous squamous cell carcinoma models, CTSL can exert tumour‐suppressive effects by promoting EGFR degradation and limiting aberrant mitogenic signalling. In the tumour microenvironment, CTSL influences tumour immune evasion, myeloid‐cell polarisation, and lymphocyte homeostasis. Translational studies have investigated CTSL in relation to prognosis and treatment response. In addition, its proteolytic activity has been exploited in engineered applications, including protease‐cleavable antibody‐drug conjugate linkers and activity‐based diagnostic probes. Conclusions Rather than acting as a universal driver, CTSL is a context‐dependent modulator in cancer biology. Although no CTSL inhibitor has yet received clinical approval due to unfavourable ADME properties, off‐target toxicity, and compensatory mechanisms, the development of selective extracellular‐targeting strategies and companion diagnostics highlights its continuing promise as a therapeutic and diagnostic target in oncology.
Related
- Microenvironmental barriers to healing in osteoradionecrosis and opportunities for regenerative intervention.
- Cathepsin G and neutrophil elastase control Leishmania infantum parasitism through TLRs-dependent induction of IFN-α and TNF-α
- Therapy-Induced Senescence in Cancer Treatment Resistance: Mechanisms, Evidence, and Translational Opportunities
- Targeting the secretory autophagy–extracellular vesicle interface: fate decisions and translational opportunities
- Post-Translational Modification Crosstalk in Gastric Cancer: Molecular Switches, Signaling Networks, and Therapeutic Opportunities, with Comparative Insights from Colorectal Cancer
BibTeX
@article{wu2026cathepsin,
title = {{Cathepsin L in cancer: Context‐dependent functions, microenvironmental regulation and translational opportunities}},
author = {Yujun Wu and Qin Huang and Zixuan Ding and Lin Fu and Mu Yang and Bi Peng and Pengbo Hu and Yuanhui Liu},
journal = {Clinical and Translational Discovery},
year = {2026},
month = oct,
doi = {10.1002/ctd2.70215},
url = {https://doi.org/10.1002/ctd2.70215},
note = {CC BY},
}
RIS
TY - JOUR
TI - Cathepsin L in cancer: Context‐dependent functions, microenvironmental regulation and translational opportunities
AU - Yujun Wu
AU - Qin Huang
AU - Zixuan Ding
AU - Lin Fu
AU - Mu Yang
AU - Bi Peng
AU - Pengbo Hu
AU - Yuanhui Liu
PY - 2026
DA - 2026/10/26
JO - Clinical and Translational Discovery
DO - 10.1002/ctd2.70215
UR - https://doi.org/10.1002/ctd2.70215
AB - Background Cathepsin L (CTSL), a lysosomal cysteine endopeptidase, is implicated in multiple facets of tumour biology beyond its canonical role in intracellular protein turnover. Objective This review provides a comprehensive synthesis of the current evidence regarding CTSL in cancer, evaluating its biochemical constraints, substrate selectivity within the cysteine cathepsin family, and context‐dependent functions across diverse malignancies. Key findings Mechanistically, across solid and haematological malignancies, such as breast and gastrointestinal cancers as well as paediatric acute myeloid leukaemia, CTSL promotes progression and therapy resistance through diverse processes, including extracellular matrix degradation, epithelial–mesenchymal transition, angiogenesis, and cell proliferation. These oncogenic functions are strongly context‐ and lineage‐dependent rather than operating through a universal mechanism. Conversely, in stratified squamous epithelia, including the epidermis and cutaneous squamous cell carcinoma models, CTSL can exert tumour‐suppressive effects by promoting EGFR degradation and limiting aberrant mitogenic signalling. In the tumour microenvironment, CTSL influences tumour immune evasion, myeloid‐cell polarisation, and lymphocyte homeostasis. Translational studies have investigated CTSL in relation to prognosis and treatment response. In addition, its proteolytic activity has been exploited in engineered applications, including protease‐cleavable antibody‐drug conjugate linkers and activity‐based diagnostic probes. Conclusions Rather than acting as a universal driver, CTSL is a context‐dependent modulator in cancer biology. Although no CTSL inhibitor has yet received clinical approval due to unfavourable ADME properties, off‐target toxicity, and compensatory mechanisms, the development of selective extracellular‐targeting strategies and companion diagnostics highlights its continuing promise as a therapeutic and diagnostic target in oncology.
SN - 2768-0622
ER -